These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 27681577)

  • 1. Update on hypertrophic cardiomyopathy and a guide to the guidelines.
    Sen-Chowdhry S; Jacoby D; Moon JC; McKenna WJ
    Nat Rev Cardiol; 2016 Nov; 13(11):651-675. PubMed ID: 27681577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine.
    Maron BJ; Ommen SR; Semsarian C; Spirito P; Olivotto I; Maron MS
    J Am Coll Cardiol; 2014 Jul; 64(1):83-99. PubMed ID: 24998133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy.
    O'Mahony C; Tome-Esteban M; Lambiase PD; Pantazis A; Dickie S; McKenna WJ; Elliott PM
    Heart; 2013 Apr; 99(8):534-41. PubMed ID: 23339826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The 2014 ESC guidelines on the diagnosis and management of hypertrophic cardiomyopathy : what is new?].
    Maisch B; Mahrholdt H;
    Herz; 2014 Dec; 39(8):919-30. PubMed ID: 25410471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
    ; Ommen SR; Ho CY; Asif IM; Balaji S; Burke MA; Day SM; Dearani JA; Epps KC; Evanovich L; Ferrari VA; Joglar JA; Khan SS; Kim JJ; Kittleson MM; Krittanawong C; Martinez MW; Mital S; Naidu SS; Saberi S; Semsarian C; Times S; Waldman CB
    J Am Coll Cardiol; 2024 Jun; 83(23):2324-2405. PubMed ID: 38727647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Ommen SR; Mital S; Burke MA; Day SM; Deswal A; Elliott P; Evanovich LL; Hung J; Joglar JA; Kantor P; Kimmelstiel C; Kittleson M; Link MS; Maron MS; Martinez MW; Miyake CY; Schaff HV; Semsarian C; Sorajja P
    Circulation; 2020 Dec; 142(25):e533-e557. PubMed ID: 33215938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Ommen SR; Mital S; Burke MA; Day SM; Deswal A; Elliott P; Evanovich LL; Hung J; Joglar JA; Kantor P; Kimmelstiel C; Kittleson M; Link MS; Maron MS; Martinez MW; Miyake CY; Schaff HV; Semsarian C; Sorajja P
    Circulation; 2020 Dec; 142(25):e558-e631. PubMed ID: 33215931
    [No Abstract]   [Full Text] [Related]  

  • 8. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
    Ommen SR; Ho CY; Asif IM; Balaji S; Burke MA; Day SM; Dearani JA; Epps KC; Evanovich L; Ferrari VA; Joglar JA; Khan SS; Kim JJ; Kittleson MM; Krittanawong C; Martinez MW; Mital S; Naidu SS; Saberi S; Semsarian C; Times S; Waldman CB
    Circulation; 2024 Jun; 149(23):e1239-e1311. PubMed ID: 38718139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.
    Lu DY; Pozios I; Haileselassie B; Ventoulis I; Liu H; Sorensen LL; Canepa M; Phillip S; Abraham MR; Abraham TP
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    ; Ommen SR; Mital S; Burke MA; Day SM; Deswal A; Elliott P; Evanovich LL; Hung J; Joglar JA; Kantor P; Kimmelstiel C; Kittleson M; Link MS; Maron MS; Martinez MW; Miyake CY; Schaff HV; Semsarian C; Sorajja P; ; O'Gara PT; Beckman JA; Levine GN; Al-Khatib SM; Armbruster A; Birtcher KK; Ciggaroa J; Dixon DL; de Las Fuentes L; Deswal A; Fleisher LA; Gentile F; Goldberger ZD; Gorenek B; Haynes N; Hernandez AF; Hlatky MA; Joglar JA; Jones WS; Marine JE; Mark D; Palaniappan L; Piano MR; Tamis-Holland J; Wijeysundera DN; Woo YJ
    J Thorac Cardiovasc Surg; 2021 Jul; 162(1):e23-e106. PubMed ID: 33926766
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators.
    Maron BJ; Casey SA; Olivotto I; Sherrid MV; Semsarian C; Autore C; Ahmed A; Boriani G; Francia P; Winters SL; Giudici M; Koulova A; Garberich R; Rowin EJ; Sears SF; Maron MS; Spirito P
    Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e005820. PubMed ID: 29625970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management and outcomes of hypertrophic cardiomyopathy in young adults.
    Baron É; Karam N; Donal E; Puscas T; Mirabel M; Bacher A; Wahbi K; Mazzella JM; Jeunemaitre X; Reant P; Hagège A;
    Arch Cardiovasc Dis; 2021; 114(6-7):465-473. PubMed ID: 33744178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertrophic cardiomyopathy: a review of etiology and treatment.
    Jurynec J
    J Cardiovasc Nurs; 2007; 22(1):65-73; quiz 74-5. PubMed ID: 17224700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk stratification and role of implantable defibrillators for prevention of sudden death in patients with hypertrophic cardiomyopathy.
    Maron BJ
    Circ J; 2010 Nov; 74(11):2271-82. PubMed ID: 20962423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Ommen SR; Mital S; Burke MA; Day SM; Deswal A; Elliott P; Evanovich LL; Hung J; Joglar JA; Kantor P; Kimmelstiel C; Kittleson M; Link MS; Maron MS; Martinez MW; Miyake CY; Schaff HV; Semsarian C; Sorajja P
    J Am Coll Cardiol; 2020 Dec; 76(25):e159-e240. PubMed ID: 33229116
    [No Abstract]   [Full Text] [Related]  

  • 16. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Ommen SR; Mital S; Burke MA; Day SM; Deswal A; Elliott P; Evanovich LL; Hung J; Joglar JA; Kantor P; Kimmelstiel C; Kittleson M; Link MS; Maron MS; Martinez MW; Miyake CY; Schaff HV; Semsarian C; Sorajja P
    J Am Coll Cardiol; 2020 Dec; 76(25):3022-3055. PubMed ID: 33229115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
    Maron BJ; Rowin EJ; Casey SA; Link MS; Lesser JR; Chan RH; Garberich RF; Udelson JE; Maron MS
    J Am Coll Cardiol; 2015 May; 65(18):1915-28. PubMed ID: 25953744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertrophic Cardiomyopathy in Children, Adolescents, and Young Adults Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
    Maron BJ; Rowin EJ; Casey SA; Lesser JR; Garberich RF; McGriff DM; Maron MS
    Circulation; 2016 Jan; 133(1):62-73. PubMed ID: 26518766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in sudden cardiac death risk prediction by the enhanced American College of Cardiology/American Heart Association strategy in Chinese patients with hypertrophic cardiomyopathy.
    Liu J; Wu G; Zhang C; Ruan J; Wang D; Zhang M; Wang L; Yang Y; Li X; Wang Y; Hui R; Zou Y; Kang L; Wang J; Song L
    Heart Rhythm; 2020 Oct; 17(10):1658-1663. PubMed ID: 32311532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: What has Changed in The Guidelines?
    Reis L; Teixeira R; Fernandes A; Almeida I; Madeira M; Silva J; Botelho A; Pais J; Nascimento J; Gonçalves L
    Arq Bras Cardiol; 2018 Jun; 110(6):524-531. PubMed ID: 30226910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.